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Abstract
Dietary fish oil (FO) modulates muscle O2 consumption and contractile function, predictive of effects on
muscle fatigue. High doses unattainable through human diet and muscle stimulation parameters used
engender uncertainty in their physiological relevance. We tested the hypothesis that nutritionally relevant FO
doses can modulate membrane fatty acid composition and muscle fatigue. Male Sprague-Dawley rats were
randomised to control (10 % olive oil (OO) by weight) or low or moderate FO diet (LowFO and ModFO)
(HiDHA tuna fish oil) for 15 weeks (LowFO: 0·3 % FO, 9·7 % OO, 0·25 % energy as EPA + DHA; ModFO:
1·25 % FO, 8·75 % OO, 1·0 % energy as EPA + DHA). Hindlimb muscle function was assessed under
anaesthesia in vivo using repetitive 5 s burst sciatic nerve stimulation (0·05 ms, 7-12 V, 5 Hz, 10 s duty cycle,
300 s). There were no dietary differences in maximum developed muscle force. Repetitive peak developed
force fell to 50 % within 62 (SEM 10) s in controls and took longer to decline in FO-fed rats (LowFO 110
(SEM 15) s; ModFO 117 (SEM 14) s) (P<0·05). Force within bursts was better sustained with FO and
maximum rates of force development and relaxation declined more slowly. The FO-fed rats incorporated
higher muscle phospholipid DHA-relative percentages than controls (P<0·001). Incorporation of DHA was
greater in the fast-twitch gastrocnemius (Control 9·3 (SEM 0·8) %, LowFO 19·9 (SEM 0·4), ModFO 24·3
(SEM 1·0)) than in the slow-twitch soleus muscle (Control 5·1 (SEM 0·2), LowFO 14·3 (SEM 0·7), ModFO
18·0 (SEM 1·4)) (P <0·001), which was comparable with the myocardium, in line with muscle fibre
characteristics. The LowFO and ModFO diets, emulating human dietary and therapeutic supplement intake,
respectively, both elicited muscle membrane DHA enrichment and fatigue resistance, providing a foundation
for translating these physiological effects to humans.
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Dietary fish oil (FO) modulates muscle oxygen consumption and contractile function, predictive 32 
of effects on muscle fatigue. High doses unattainable through human diet and muscle stimulation 33 
parameters used engender uncertainty in their physiological relevance. We tested the hypothesis 34 
that nutritionally relevant FO doses can modulate membrane fatty acid composition and muscle 35 
fatigue.  Male Sprague-Dawley rats were randomised to control (10% olive oil (OO) by weight) 36 
or low or moderate FO diet (hiDHA tuna-fish oil) for 15 weeks (LowFO: 0.3% FO, 9.7% OO, 37 
0.25% energy as EPA+DHA; ModFO: 1.25% FO, 8.75% OO, 1.0% energy as EPA+DHA). 38 
Hindlimb muscle function was assessed under anaesthetic in vivo using repetitive 5s-burst, 39 
sciatic nerve stimulation (0.05ms, 7-12V, 5Hz, 10s duty cycle, 300s). There were no dietary 40 
differences in maximum developed muscle force. Repetitive peak developed force fell to 50% 41 
within 62±10s in control took longer to decline in FO-fed rats (LowFO 110±15s; ModFO 42 
117±14s) (p<0.05). Force within bursts was better sustained with FO and maximum rates of 43 
force development and relaxation declined more slowly.  The FO-fed rats incorporated higher 44 
muscle phospholipid DHA relative percentages than control (p<0.001). Incorporation of DHA 45 
was greater in fast-twitch gastrocnemius (Control 9.3±0.8%, LowFO 19.9±0.4, ModFO 46 
24.3±1.0) than slow-twitch soleus muscle (Control 5.1±0.2, LowFO 14.3±0.7, ModFO 18.0±1.4) 47 
(p<0.001), which was comparable to myocardium, in line with muscle fibre characteristics.  The 48 
LowFO and ModFO diets, emulating human dietary and therapeutic supplement intake 49 
respectively, both elicited muscle membrane DHA enrichment and fatigue resistance, providing 50 




The gradual decline in repetitive force development that defines muscle fatigue can be 53 
attenuated by exercise training or dietary modulation of carbohydrate intake to optimise 54 
glycogen storage and availability, but there are no other recognised physiological approaches to 55 
fatigue prevention. Increased membrane phospholipid incorporation of long-chain n-3 56 
polyunsaturated fatty acid (LC n-3 PUFA) docosahexaenoic acid (DHA; 22:6n-3), obtained from 57 
the diet via fish or fish oil, is associated with increased efficiency of oxygen utilisation in the 58 
heart independent of heart rate 
(1)




. Dietary fish oil is also associated with increased whole human body oxygen efficiency during 60 
exercise 
(3)
, implicating modified skeletal muscle oxygen consumption. In humans and other 61 
vertebrate animals, DHA is the most unsaturated fatty acid present in cell membranes, 62 
accounting for up to 5% of all phospholipid fatty acids in most tissues.  However, skeletal 63 
muscle 
(4-7)
 has a predisposition to greater DHA incorporation, well beyond its relative 64 
percentage amongst circulating fats 
(4, 8)
.  Skeletal muscle shares this propensity for concentrated 65 
phospholipid DHA incorporation with other highly excitable tissue (myocardium, brain and 66 
retina) 
(4, 9, 8, 5, 10, 11)
.  These parallels in membrane fatty acid composition, together with certain 67 
shared physiological properties 
(12)
, imply an important role for adequate intake of LC n-3 PUFA 68 
supporting striated muscle physiology 
(13)
.   69 
 70 
High dietary intakes of fish oil in the rat are associated with apparent resistance of contracting 71 
skeletal muscle to fatigue 
(14, 15)
.  Earlier in vitro studies suggested a role of essential fatty acids 72 
(both n-6 PUFA and n-3 PUFA) in maintaining skeletal muscle function, compared to animals 73 
fed an essential fatty acid deficient diet 
(16)
.  In these and other animal and human studies, 74 
physiological effects of LC n-3 PUFA have largely been investigated in relation to high intakes 75 
of fish oil 
(13, 7)
, commonly ranging from five to over ten percent of diet by weight in animals or 76 
five to eight grams per day in humans.  However, dose-response studies show that the rat 77 
responds to very small dietary intakes of fish oil with large changes in myocardial membrane 78 
DHA incorporation 
(17)
.  This suggests that physiological changes may be achieved with lower, 79 
nutritionally relevant dietary interventions.  80 
 81 
While studies already reveal potential influences of LC n-3 PUFA on skeletal muscle function, 82 
the single twitch model of contraction employed in those dietary studies 
(15, 14)
 or tetanic 83 
stimulation protocols in other fatigue studies may not best represent submaximal and usual 84 
muscle activity 
(18, 19)
.  Moreover, the translation of results to human nutrition must be made 85 
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cautiously, since the high doses of fish oil previously used 
(15, 14, 3)
 are well beyond what could be 86 
obtained in the human diet. 87 
 88 
The present study employed the in vivo muscle function model of autologous pump-perfused 89 
hindlimb in anaesthetised rats. We developed this model 
(20)
 in order that the experiments could 90 
be carried out at physiological temperature to avoid the widely accepted influence of 91 
temperature on fatigue development and at physiological blood flow and arterial oxygen content 92 
so that the muscle could be oxygenated at physiological levels throughout and not randomly 93 
subjected to hypoxia or ischaemia 
(21, 19)
. The autologous pump-perfusion also ensured that 94 
muscle blood flow was controlled independently of intra-experimental fluctuations or dietary 95 
influences on cardiac output or blood pressure 
(20)
. For this study we further incorporated a 96 
stimulation protocol for the sciatic nerve: gastrocnemius-soleus-plantaris muscle bundle 97 
designed as a more physiological model to mimic functional fatigue. Two fish oil doses, derived 98 
from the studies of Slee and co-workers 
(17)
, were chosen to best replicate human nutritional and 99 
therapeutic supplement equivalents respectively. This study tested the hypothesis that membrane 100 
change produced by low intakes of fish oil would be associated with resistance to 101 
physiologically relevant muscle fatigue.  102 
 103 
Experimental Methods 104 
Animals 105 
Eighteen adult male Sprague-Dawley rats were housed two per cage at 23-25ºC on a 12 hour 106 
light-dark cycle in the University of Wollongong’s Animal facility. Experiments were approved 107 
by the University of Wollongong Animal Care and Ethics committee and were conducted 108 
according to the Australian Code of Practice for the Care and Use of Animals for Scientific 109 
Purposes (NHMRC, 2004). The research was conducted according to the ARRIVE guidelines 110 




Rats were obtained at 7 weeks of age (Animal Resources Centre, Perth, Australia) and fed on a 113 
standard laboratory chow prior to randomly allocating them to be fed one of three prefabricated 114 
diets ad-libitum for 15 weeks from 8-10 weeks of age.  The diets were prepared as previously 115 
developed for similar animal feeding studies 
(15, 17)
. Based on the American Institute of Nutrition 116 
AIN 93M diet 
(23)
, they contained a balanced mix of macro and micronutrients to avoid any 117 
nutritional deficiencies. All diets contained 10% fat by weight (100g.kg
-1
). Two sources of fat were 118 
used in this study to produce a control diet (10% olive oil (OO)), low fish oil (LowFO) diet 119 
(0.31% FO, 9.7% OO) or a moderate fish oil (ModFO) diet (1.25% FO, 8.75% OO). Olive oil 120 
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was provided as “extra light” olive oil, being largely devoid of the antioxidant polyphenols 121 
found in less refined oils. Olive oil consisted principally of oleic acid (18:1, 75%) and provided a 122 
minimum concentration of linoleic acid (18:2n-6) to avoid essential fatty acid deficiency 
(2)
. The 123 
fish oil was provided as HiDHA tuna fish oil (Nu-Mega Lipids, Altona, Australia), containing 124 
29% DHA and 7% EPA, 20% palmitic acid (16:0) and 14% oleic acid as the major fatty acids. 125 
The fatty acid profiles of the control and fish oil diets are provided in Table 1. The energy intake 126 
from these diets, based on a 300g rat eating 20g.d
-1
 was approximately 325kJ.d
-1
.  The LowFO 127 
diet (3.1g.kg
-1
) was selected to emulate a human dietary EPA+DHA intake of 0.24% energy 128 
calculated equivalent to a human intake of 570mg.d
-1
 EPA+DHA and is a dose that 129 
approximately doubles myocardial DHA relative percentage 
(17)
.  The ModFO diet (12.5g.kg
-1
) 130 
was selected to emulate a human therapeutic supplement EPA+DHA intake of 1.0% energy 131 
equivalent to 2.3g.d
-1
 EPA+DHA and is a dose that produces changes in n-3 PUFA relative 132 
percentage that approach the asymptote of the dose-response curve for n-3 PUFA incorporation 133 
in cardiac 
(17, 8)
 and skeletal muscle 
(5)
.  This ModFO dose, already shown to be cardioprotective, 134 
is the lowest dose that has been tested physiologically to date 
(24)
.  135 
 136 
Surgical hindlimb preparation  137 
The in vivo autologous, pump-perfused rat hindlimb preparation used in the present study has 138 
been described in detail and validated physiologically
(20, 25)
. Briefly, rats were anaesthetised 139 
(pentobarbitone sodium, 60mg.kg
-1
 i.p.) and maintained throughout the experiment with 140 
supplementary injections of 20mg.kg
-1
 i.p. pentobarbitone sodium. Rat body temperature was 141 
maintained at 37ºC with the aid of a heated perspex chamber maintained at 31±1ºC and ancillary 142 
radiant heat lamp.  Animals were ventilated at 60 breaths per minute and systemic blood 143 
pressure was monitored via the carotid artery. The left sciatic nerve was isolated for electrical 144 
stimulation of the hindlimb and the gastrocnemius-soleus-plantaris muscle bundle was attached 145 
to a force transducer (FT03C, Grass Technologies, West Warwick, RI) at the Achilles tendon. A 146 
pump-perfusion system supplied the hindlimb muscles of the left leg below the knee with 147 
oxygenated arterial blood 
(20)
. The femoral vein was cannulated for post-muscle blood sampling 148 
with venous blood returned passively to the systemic circulation. The extracorporeal perfusion 149 
circuit was primed with 6% dextran (w/v) (dextran 60, Sigma-Aldritch, NSW, Australia) and 150 
5000IU heparin.100ml
-1
 (Sigma-Aldrich, NSW, Australia) in normal saline. The extracorporeal 151 
circuit plus perfused muscle held a total volume of approximately 3mL. 152 
 153 
Blood flow and muscle stimulation 154 
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Once all cannulations were in place and blood flowed freely throughout the system, the pump 155 
was engaged to perfuse the left leg at 1 mL.min
-1
, supporting resting blood flow requirements 156 
(20)
, for 30 min equilibration prior to stimulating muscle contraction. Hindlimb perfusion 157 
pressure was monitored via a pressure transducer (Argon CDXIII, Maxim Medical, USA) distal 158 
to the pump. Sciatic nerve was stimulated at supramaximal voltage to elicit muscle contraction 159 
and the muscle stretched to optimal length for maximal twitch contraction force.  Perfusion flow 160 
was increased to 1.5 mL.min
-1
 to support the increased oxygen demand 
(20)
 for the duration of the 161 
muscle contraction protocol.  Contractions were evoked using 5s burst trains of pulses (5Hz, 7-162 
12V, 0.05ms) with 10s duty cycle for 5 min (Figure 1).  163 
 164 
Muscle samples and fatty acid analysis 165 
Gastrocnemius and soleus muscles were separated from the contralateral, unstimulated hindlimb 166 
during surgical preparation of the perfused limb and the left ventricle was collected on 167 
completion of the hindlimb stimulation protocol, after euthanasia by rapid exsanguination under 168 
anaesthetic.  Samples were rapidly taken from three sites: the left ventricle free wall; the entire 169 
soleus muscle cleared of connective tissue; and the lateral superficial gastrocnemius muscle 170 
belly.  All samples were rapidly frozen and stored at -80°C. Skeletal and cardiac muscle samples 171 
(100-200mg) underwent total lipid extraction using a modification of the Folch method 
(26)
. 172 
Phospholipids were isolated from the total muscle lipid by solid phase extraction using silica 173 
Sep-pak™ cartridges (Waters, Australia).  Fatty acid methyl esters were prepared by direct 174 
transesterification 
(27)
 of phospholipids and analysed by gas chromatography 
(17)
 using a 175 
Shimadzu GC-17A with flame ionisation detection.  Individual fatty acid peaks on the 176 
chromatogram were identified by comparison to authentic fatty acid methyl ester standards 177 
(Sigma-Aldrich Corporation, Castle Hill, NSW) and Nu-Chek-Prep Inc. (Elysian, MN, USA) 178 
and expressed as percentage of total fatty acids in the phospholipid fraction. Peroxidisability 179 
index was calculated as the sum of bis-allelic hydrogen atoms (located on the methylene carbon 180 
atoms between two double bonds) according to the formula:  (% dienoic acids × 1) + (% 181 




Data analysis and calculations 184 
Contractile force was recorded and contraction characteristics analysed using LabView for 185 
Windows with custom programming. Force and contraction characteristics were analysed for the 186 
first and 25
th
 (last) contraction in each 5s contraction burst (Figure 1). Fatigue was recorded: a) 187 




 contraction within each burst; and b) as the 188 
decline in force between contraction bursts over time. The rate of fatigue between bursts was 189 
7 
 




 contractions in each burst, as the time taken for the individual 190 
contraction developed force to decline to 50% of the maximum peak contraction force. 191 
 192 
Statistics 193 
Researchers were blinded to the allocation of animals to dietary groups until data collection and 194 
analysis was completed.  Sample size calculation for membrane fatty acids estimated n=4 to 195 
detect 25% relative change in DHA (80% power for dose, α=0.05, x̄ = 7.69%, SD = 1.35%
(17)
); 196 
and for contractile function, based on a 2Hz continuous stimulation protocol n=5 required to 197 
detect 35% increase in time to fatigue (80% power, α=0.05, x̄ = 522s, SD = 142s). Results are 198 
expressed as mean±SEM. Two-way repeated measures ANOVA was used to analyse between 199 
muscle-type differences and effects of diet on fatty acid incorporation into muscle tissues, with 200 
tissue and diet main effects and (diet × tissue) interaction, followed by Tukey’s post-hoc 201 
comparison of means (Statistix for Windows, Analytical Software, Tallahassee, USA). Statistical 202 
significance was accepted at p<0.05.  203 
 204 
Results 205 
Effects of diet on body weight and muscle weight 206 
One rat was lost to the experiment due to excessive blood loss during preparative surgery, with 207 
no experimental data obtained, leaving final numbers of: Control n = 6; LowFO n=4; ModFO n 208 
= 7 for all measures. After 15 weeks of dietary intervention there were no significant dietary 209 
differences in body mass (Control: 463±30g, LowFO: 457±44g, ModFO: 464±12g) (p>0.05); 210 
gastrocnemius-soleus-plantaris mass (Control: 3.02±0.12g, LowFO: 3.15±0.15g, ModFO: 211 
3.03±0.09g) (p>0.05) or ratio of gastrocnemius-soleus-plantaris mass / tibia-length (GSP/TL; 212 
Control: 6.91±0.24, LowFO: 7.30±0.24, ModFO: 6.89±0.15) (p>0.05). 213 
 214 
Effect of muscle type on membrane phospholipid fatty acid composition 215 
Statistically significant, between-tissues differences were observed in most fatty acids. In control 216 
animals, the few exceptions were: no between-tissues differences in the minor LCn-3 PUFA, 217 
DPA (<1%) or EPA (not detected); or in linoleic acid (18:2 n-6), which was the most abundant 218 
individual fatty acid at about 20% of total. There were no differences in membrane 219 
peroxidisability index between tissues in control animals (Table 2).  220 
 221 
In control animals, the gastrocnemius muscle had significantly lower percentages of the 222 
saturated fatty acid (SFA) stearic acid 18:0 and monounsaturated fatty acid (MUFA) oleic acid 223 
18:1 than either soleus or myocardium, which were not significantly different to each other. In 224 
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contrast, gastrocnemius had significantly higher percentages of: the SFA palmitic acid 16:0; and 225 
LC n-3 PUFA DHA; and lower ratio of n-6/n-3 PUFA, than either the soleus or myocardium, 226 
which were not significantly different to each other (Table 2).  In soleus and myocardium, the 227 
principal SFA 18:0 was found at twice the percentage of 16:0, whereas in gastrocnemius the two 228 
were approximately equal.  There were significant variations with tissue type in total relative 229 
percentages of SFA (gastrocnemius > soleus, myocardium), MUFA (soleus > myocardium, 230 
gastrocnemius) and PUFA (myocardium > gastrocnemius, soleus). 231 
 232 
With respect to long-chain PUFA (Table 2), gastrocnemius muscle exhibited greater: 22:6n-3 233 
DHA; total n-3 PUFA; and lower: 20:4n-6 arachidonic acid; 18:2n-6 linoleic acid; total n-6 234 
PUFA percentages; and n-6/n-3 PUFA ratio, compared to either soleus or left ventricle (all 235 
p<0.001). The soleus further differed from the left ventricle having lower percentages of: 20:4n-236 
6 arachidonic acid; and total n-6 PUFA (all p<0.001).  The LC n-3 PUFA 20:5n-3 EPA was not 237 
detectable in any of the muscle tissues from control animals. 238 
 239 
Effect of FO diets on membrane fatty acid composition 240 
There were significant effects of FO diets on both types of skeletal muscle and cardiac 241 
membrane composition (Table 2). The major effects of dietary FO were: increased percentages 242 
of DHA (22:6n-3, p<0.001) and reduced AA (20:4n-6, p<0.001). Smaller changes were observed 243 
in other fatty acids, including reduced percentages of LA (18:2n-6, p<0.001) and a small but 244 
statistically significant incorporation of EPA (20:5n-3, p<0.001). These changes resulted in 245 
increased relative percentage of total n-3 PUFA (p<0.001) and peroxidisability index (p<0.001) 246 
and decreased relative percentage of total n-6 PUFA (p<0.001) and n-6/n-3 PUFA ratio 247 
(p<0.001). The incorporation of n-3 PUFA in exchange for n-6 PUFA was greater in the 248 
gastrocnemius muscle (all p<0.05, diet*tissue interaction).  249 
 250 
In gastrocnemius muscle the higher dose ModFO diet was associated with significant further 251 
decrease in relative percentage of AA and increased DHA compared to the LowFO diet, with 252 
further reduced total n-6 PUFA and increased total n-3 PUFA (p<0.05) (Table 2).  In soleus 253 
muscle and myocardium, the ModFO diet was associated with a small but significant further 254 
lowering in relative percentage of total n-6 PUFA (p<0.05) compared to the LowFO diet but no 255 
significant differences in DHA, LA, AA or any other major individual fatty acid, or total n-3 256 




Force characteristics 259 
Maximum peak contractile force was reached within the first few 5s bouts of 5Hz stimulation.  260 
The first contraction in each repeated 5s bout was characterised by a rapid decline from bout to 261 
bout over 2-2.5 min to a plateau level which was maintained over the final minutes of the 262 
protocol (Figure 1a).  The developed tension of the 25
th
 (last) contraction in repeated bouts also 263 
declined rapidly from bout to bout over 1-1.5 min, to a plateau level maintained over the final 264 
minutes of the protocol (Figure 1b). Peak developed force declined from contraction to 265 
contraction (1 to 25) within the 5s bouts (Figure 2).   266 
 267 
There were no dietary differences in the maximum peak force (Control: 222±14; LowFO: 268 
212±4; ModFO: 218±9 N.100g
-1
 muscle mass) (p>0.05).  Peak developed force declined over 269 
time and significant diet*time interactions were evident (contraction 1 p=0.020, contraction 25 270 
p<0.001).  A significantly longer time was taken for 1
st
 contraction force to decline by 50% in 271 
the FO groups compared to control (Table 3) (p<0.02) (Figure 1a) and developed force was 272 
better sustained in the FO groups throughout and at the end of the five minutes of contractions 273 
(Figure 1) (contraction 1, contraction 25 p<0.001).  There were no significant differences 274 
between LowFO and ModFO groups (contraction 1 p=1.000, contraction 25 p=0.993). 275 
 276 
Peak developed force declined within each 5s burst (contraction 1-25), and over the first 60s 277 
there was significantly less within-burst decline in the FO groups compared to control (Figure 278 
2). The FO groups took significantly longer for the 25
th
 contraction peak developed force to 279 
decline by 50% (Table 3) (p<0.05). Maximum rates of force development and relaxation (Figure 280 
3) slowed markedly over the first 60 to 100s and the decline in contraction and relaxation 281 
velocity was significantly greater in the control muscle than in FO muscles over the duration of 282 
the stimulation protocol. There were no significant differences between the LowFO and ModFO 283 
diets. 284 
 285 
Hindlimb perfusion pressure and resistance 286 
There were no significant differences in resting hindlimb perfusion pressures across dietary 287 
groups (at 1 mL.min
-1
: Control 73±11 mmHg; LowFO 77±2; ModFO 76±4), (at 1.5mL.min-1: 288 
Control 106±13 mmHg; LowFO 109±6; ModFO 104±5).  Mean hindlimb perfusion pressure (at 289 
1.5mL.min
-1
) decreased during muscle contractions in FO dietary groups (p<0.05) with a non-290 
significant trend in the control group (p=0.08) (Control 92±13 mmHg; LowFO 85±3; ModFO 291 
88±4). There were no significant differences in perfusion pressure between dietary groups at rest 292 
or during muscle activity (p>0.05). A significantly greater percentage fall in mean hindlimb 293 
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vascular resistance occurred during muscle contraction in the FO dietary groups compared to 294 
control (p=0.010). 295 
 296 
Discussion 297 
Membrane phospholipid fatty acid composition of rat skeletal muscle was highly responsive to 298 
dietary fish oil, and elevated incorporation of DHA was associated with resistance to muscle 299 
fatigue.  This was achieved with a low-dose human nutritional equivalent of 1-2 fish meals per 300 
week with little further dose-related changes, in either the membrane composition or contraction 301 
parameters, obtained from the higher dose human therapeutic equivalent of 6-7 g of fish oil per 302 
day 
(17)
. The tuna fish oil supplement used in this study, with its high proportion of DHA, is 303 
consistent with the predominance of DHA in the human diet when obtained through common 304 
food fish 
(29)
 and in contrast to most dietary fish oil supplements that commonly provide 305 
EPA:DHA in the ratio 180:120 mg.g
-1
.  The in vivo hindlimb perfusion model permitted 306 
examination of dietary effects on muscle function and fatigue under well-oxygenated, well-307 
perfused, appropriate physiological conditions 
(20)
.  Effects on fatigue could be directly 308 
attributable to change in muscle function without the potential confounding effects of dietary 309 
fish oil on cardiovascular function or behaviour.   The membrane changes and fatigue resistance 310 
were achieved using much lower dietary LC n-3 PUFA concentrations than previously reported 311 
in the literature.  From these intakes, both of which were within a range that could reasonably be 312 
modulated nutritionally in man, skeletal muscle and myocardium incorporated high relative 313 
percentages of LC n-3 PUFA DHA into membrane phospholipid. Muscle types exhibited 314 
differences in fatty acid composition in accord with their contrasting physiological functions and 315 
fibre type characteristics. Soleus muscle and myocardium had comparable patterns of fatty acid 316 
incorporation including high DHA incorporation, in contrast to the fast twitch, fatigable 317 
gastrocnemius muscle, which incorporated even higher relative percentages of DHA. 318 
 319 
The lower of the two fish oil doses increased gastrocnemius and soleus muscle membrane DHA 320 
incorporation by 10% of the total fatty acids despite providing less than 1% of all the fatty acids 321 
in the diet.  In contrast, linoleic acid diminished slightly in the membranes, despite being present 322 
as 8% of dietary fat and in an n-6/n-3 PUFA ratio of 5:1 in the lowFO diet, with the LA 323 
concentration almost 10 times that of DHA.  Concomitant reductions occurred in membrane 324 
arachidonic acid of less than 4% in skeletal muscle or 6% in the heart.  Thus, skeletal muscle of 325 
the rat incorporated DHA into membrane phospholipid well above its relative percentage in the 326 
diet, as seen with high dietary fish oil doses 
(5)
 and against an unfavourable ratio of n-6/n-3 327 
PUFA.  This finding confirms studies of skeletal muscle from developing rats and studies of rat 328 
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myocardium that show the absolute delivery of DHA is more important than its ratio to n-6 329 
PUFA 
(17, 6)
, even at these low intakes of LC n-3 PUFA. Although there can be no doubt that 330 
dietary n-6/n-3 PUFA ratio powerfully influences n-3 PUFA membrane incorporation when it is 331 
dependent upon the shorter chain precursor alpha-linolenic acid (18:3n-3) 
(30)
, this is due to 332 
competition for enzyme sites for desaturation or elongation limiting metabolic conversion to 333 
EPA and DHA.  The current study demonstrated that the incorporation into membrane 334 
phospholipids is not subject to the same competition and confirms the previously reported lack 335 
of influence of dietary n-6 PUFA on LC n-3 PUFA incorporation into rat myocardium 
(17)
 or for 336 
clinical effect 
(31)
.  Striated muscle membranes preferentially incorporate DHA and this is further 337 
illustrated by the very low incorporation of EPA into skeletal muscle or myocardium despite 338 
significant dietary presentation in this study or when it is provided in purified form in the diet 
(32)
 339 
or as high EPA fish oil that delivers plasma fatty acid EPA well in excess of DHA 
(8)
. Some 340 
tissues e.g. platelets, preferentially incorporate EPA and the underlying physiological basis for 341 
differential incorporation is not known. 342 
 343 
The slow contracting, oxidative and fatigue resistant soleus muscle, which provides slow-to-344 
fatigue ankle stability and balance is in many ways similar to ventricular myocardium. Soleus 345 
muscle and myocardium share a common isoform of myosin heavy chain that exhibit low basal 346 
rates of ATP consumption (termed MHCslow in type I muscle fibres and MHCβ in ventricular 347 
myocardium) 
(33)
. The ATP reserve capacity associated with MHCslow and the lower ATP cost 348 
for any developed tension in type I fibres 
(34)
 confers ATP conservation and fatigue resistance on 349 
soleus muscle 
(35)
.  In contrast, in terms of fibre type, the portion of gastrocnemius muscle 350 
sampled for fatty acid analysis in this study typically comprises mainly fast glycolytic / type IIb 351 
fibres with few of the slow twitch, oxidative and fatigue resistant type I fibres that almost 352 
exclusively make up the soleus muscle 
(36, 37)
. Type II fibres are characteristically glycolytic, fast 353 
twitch and provide short-term power generation.  They are rich in MHC2 isoforms 
(33)
, which 354 
exhibit high rates of ATP consumption and low ATP reserve 
(34)
, making them rapidly subject to 355 
fatigue with extended use. Preferential incorporation of DHA into fast contracting, powerful 356 
gastrocnemius muscle compared to the slower contracting soleus has previously been reported in 357 
developing rats 
(6)
.  A similar very high incorporation of DHA into faster compared to slow 358 
muscle types is emphasised in species such as the rattlesnake and the hummingbird, which 359 
possess muscle groups of even more extreme contrast in contraction speed within the one animal 360 
(38)
. The higher retention of DHA in gastrocnemius of non-supplemented rats may reflect an 361 
adaptive response to the higher maximum rates of ATP turnover of the largely fast-twitch 362 




The dietary fish oil-induced proportional increases in membrane DHA increased the unsaturation 365 





, however this is contrary to what was borne out in the 367 
physiological measures of fatigue.  Similarly, in myocardium the increase in peroxidisability 368 
induced by increased membrane DHA is paradoxically associated with reduced ischaemia-369 
reperfusion fatty acid peroxidation and oxidative damage 
(28, 40)
.  This has been attributed to an 370 
adaptive increase in activity of superoxide dismutase (SOD) and other endogenous antioxidant 371 
enzymes
(40-42)
.  It suggests that chronically increased membrane peroxidisability induces chronic 372 
but non-damaging oxidative stress and adaptation in the same way that acute exercise induces 373 
oxidative stress, yet chronic exercise upregulates antioxidant mechanisms and promotes fatigue 374 
resistance
(43)
.  Alternatively, it was recently reported that antiarrhythmic actions of DHA are 375 
enhanced by concomitant promotion of oxidation by H2O2 and inhibited by antioxidants, effects 376 
attributed to the specific non-enzymic oxidative production of DHA-derived neuroprotectins 
(44)
.  377 
Irrespective of the mechanism, increased peroxidisability of the membranes by enhanced DHA 378 
content is associated with protective rather than damaging effects under oxidative stress. 379 
 380 
Non-dietary, adaptive increases in DHA incorporation and lower tissue n-6/n-3 PUFA ratio 
(45)
 381 
occur commonly in response to stresses in a variety of tissues including: human exercising 382 
skeletal muscle 
(46)
; aging human heart 
(47)
; human placenta at altitude 
(48)
; chronic hypoxic rat 383 
heart 
(49)
; and chronic catecholamine stress in rat heart 
(47)
. An adaptive increase can be seen 384 
across mammalian species (including man) in relation to high basal metabolic rate or resting 385 
heart rate, where the whale with its very low heart rate and high LC n-3 PUFA intake has very 386 
low myocardial DHA, in contrast to the mouse that has a very high heart rate, yet very high 387 
cardiac DHA relative percentage despite low LC n-3 PUFA intake 
(47, 45)
.  In direct contrast, 388 
dietary intervention to raise cardiac DHA is associated with slower heart rates and 389 
preconditioning protection against these stresses 
(2, 45, 13)
. A similar observation applies to the 390 
restriction of acute muscle fatigue with dietary n-3 PUFA 
(15, 14)
 in contrast to the preferential 391 
incorporation of DHA and lower n-6/n-3 PUFA ratio in the more rapidly fatiguing 392 
gastrocnemius 
(6)
 and this may be related to the greater metabolic stress prevalent in type II 393 
fibres.  394 
 395 
The upper dose ModFO (1.25% FO) diet induced DHA incorporation in gastrocnemius to the 396 
same extent as reported previously with high dose 7% FO supplementation in the similar, mixed 397 
fibre type vastus lateralis muscle 
(14)
. In the current study there was little displacement of tissue 398 
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linoleic acid compared to earlier studies that used high fish oil doses. With diets in those studies 399 
delivering six times the DHA dose and a n-6/n-3 PUFA ratio of  <0.2, it is evident that previous 400 
research has used fish oil doses far in excess of requirements for maximal effect.  401 
 402 
The modulation of rat muscle phospholipid fatty acid composition, as a result of these small fish 403 
oil intakes, induced marked resistance to muscle fatigue in vivo without influencing the initial 404 
peak force of contraction of the hindlimb. Fatigue in the contracting hindlimb could be 405 
characterised in terms of: extent of decline in twitch force within the 25 contractions of any 5s 406 
burst; extent of decline in twitch force from burst to burst (which has a recovery component); the 407 
time course of the decline in twitch force; the decline in maximum rate of force production and 408 
relaxation; and the time course of those changes. The dietary fish oil markedly attenuated the 409 
decrease in muscle force production and extended the time course of well sustained isometric 410 
force production. In other words, the hindlimb muscles of animals fed fish oil were able to 411 
complete more contractions at a force closer to their peak isometric tension. In skeletal muscle, 412 
when force is sustained at a higher relative tension over time, it is explained by the optimal 413 
coupling relationship between cellular ATP demand, inherently the efficiency of ATP use by the 414 
contracting cell, and the metabolic supply 
(50, 51)
. Furthermore, while muscles sustained higher 415 
peak contractile force for longer after fish oil feeding, the attenuation in decline in rates of force 416 
production and relaxation also implies an optimal coupling of net Ca
2+
 turnover and cellular 417 




Notably, the greatest effect of dietary fish oil, retarding fatigue, occurred in the earliest phase of 421 
contraction, which corresponds to the highest rate of tension decline from peak force. With 422 
single pulse or tetanic burst contractions, fatigue occurs much more rapidly in fast, type II 423 
muscle fibres than in slow, type I fibres in shortening or isometric contractions 
(21, 19)
. This 424 
response is likely due to the greater part of the hindlimb muscle bundle representing fast, type II 425 
fibres, densely packed with sarcoplasmic reticulum and expressing high sarcoplasmic reticulum 426 
Ca
2+
ATPase (SERCA) concentration, a requirement to sustain rapid force production and 427 
relaxation. Highly effective SERCA, like those in the powerful muscle fibres, rely on the 428 
phospholipid environment to carry out rapid removal of calcium against its concentration 429 
gradient 
(53)
. There is strong evidence that when DHA makes up a high proportion of the 430 
membrane fatty acids, this process of Ca
2+
 pumping is optimised 
(38)
, thus sustaining force 431 




While this study demonstrates a clear association between dietary fatty acids, muscle 434 
incorporation of DHA and fatigue resistance, it does not identify the mechanisms of fatigue that 435 
are affected.   Since fish oil feeding does not modify glycogen storage or attenuate metabolic 436 
acidosis during fatiguing muscle stimulation 
(15)
, we can exclude the two most common 437 
interventional approaches used ahead of exercise to improve muscle function: promotion of 438 
glycogen storage; and metabolic alkalosis inducable by sodium bicarbonate ingestion 
(54)
.  We 439 
must therefore consider one or more of the many other cellular mechanisms potentially 440 
underlying fatigue-resistance 
(21, 19)
. Whilst they are not readily directly examinable in vivo 
(19)
, 441 
some insight into potential mechanisms of action of LCn-3 PUFA fatigue resistance may be 442 
gained from comparison to interventions that, in contrast to fish oil, enhance muscle fatigue.  443 
 444 
The pattern of improved muscle function by fish oil relative to control contrasts with the effects 445 
that the β2 adrenoceptor agonist clenbuterol has on muscle function. Chronic clenbuterol 446 
treatment has found some popularity in body building for its promotion of muscle hypertrophy, 447 
but it significantly slows relaxation and decreases resistance to fatigue in fast twitch muscle 448 
fibres 
(55)
.  Clenbuterol’s functional effects appear linked to intracellular Ca
2+
 homeostasis, 449 




. The decline in SR Ca
2+
 and slow SR Ca
2+
 reuptake, with 450 
the latter contributing to slowed isometric relaxation, are believed to underpin fatigue in both 451 
fast and slow twitch muscles under tetanic 
(56)
 or non-tetanic stimulation 
(57, 58)
.  If Fish oil were 452 
to prevent SR Ca
2+
 leakage and promote SR Ca
2+
 reuptake, this could explain the fatigue 453 
resistance.  Indeed, such effect has been observed in myocardium in which altered Ca
2+
 handling 454 
is recognised to play a part in DHA action in myocardial intracellular signalling, with modulated 455 
SR Ca
2+
 leakage implicated in cardiac pacemaker slowing and arrhythmia prevention in cardiac 456 
muscle 
(13)
.  Both direct and indirect evidence shows increased efficiency of SR Ca
2+
 handling as 457 
a basis for prevention of arrhythmia 
(44, 1)
 and reduced mitochondrial Ca
2+
 uptake as a basis for 458 
increased oxygen efficiency 
(1)
 or as the basis for reduced mitochondrial pyruvate dehydrogenase 459 
activity 
(59)
 in rat myocardium after fish oil feeding.  However the evidence is equivocal with 460 
another study finding that dietary fish oil has little influence on cardiac SERCA activity and may 461 




.  Moreover, an in vitro study of SR 462 





, which would predict slower relaxation and increased energy 464 
requirements and fatigability, the opposite to what is actually observed in vivo during muscle 465 
contraction in the present study.  Further studies are needed to investigate the role of altered Ca
2+
 466 
homeostasis in the effects that membrane incorporation of DHA has on muscle fatigue.  467 
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Further studies are also required to identify effects more specifically in fast and slow twitch fibre 468 
types in accordance with differences in DHA incorporation. The improved muscle function 469 
during the early fast-fatiguing component of the non-tetanic repetitive burst stimulation protocol 470 
implicates fast, type II fibres in a primary role in this study, in line with the predominance of 471 
gastrocnemius muscle in the contracting bundle. However, slow type I fibres and involvement of 472 
soleus muscle are also implicated in DHA effects by the sustained greater force and better 473 
sustained rates of force development observed after the early fatigue phase, plus the continued 474 
greater recovery between contraction bouts after fish oil feeding. While myocardium typically 475 
does not fatigue acutely, contractile function and relaxation do decline significantly in heart 476 
failure and this can be counteracted by feeding with fish oil 
(62, 63)
. The patterns of enhanced 477 
skeletal muscle fatigue in rats with heart failure 
(21)
 suggest a benefit could be gained by 478 
increasing membrane DHA.   479 
 480 
This study demonstrated that marked changes in muscle membrane fatty acid composition 481 
together with resistance to muscle fatigue are achievable in rat skeletal muscle with only small 482 
dietary supplements of LC n-3 PUFA, in a range readily compatible with human nutrition 
(13)
. 483 
The low effective dose and the DHA rich tuna fish oil supplement replicate human dietary 484 
patterns achievable from eating a low-moderate intake of fish, and provide a basis for translating 485 
to humans, the physiological observations herein and those previously made using high doses of 486 
fish oil in animals. Furthermore, tissue differences in membrane fatty acid composition suggest 487 
specific incorporation of fatty acids reflective of physiological function, with the fatigue-488 
resistant slower-contracting soleus muscle and myocardium exhibiting many compositional 489 
similarities contrasting to the highly-fatigable fast-contracting gastrocnemius muscle. Of 490 
particular note, whilst it is generally incorporated well in all striated muscle, DHA was innately 491 
incorporated to higher relative percentages in the gastrocnemius compared to the soleus muscle 492 
and myocardium without any dietary intervention as well as in response to fish oil feeding, 493 
perhaps reflecting an adaptive response to the higher peak metabolic demand and fatigability of 494 
the predominant type II muscle fibres. The large changes in composition and function achieved 495 
with only small additions of fish oil to the diet suggests that DHA may be an essential 496 
component of striated muscle for optimal healthy function and that the failure to include regular 497 
fish or fish oil in the diet might lead to a deficiency condition reflected in susceptibility to 498 
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Table 1: Dietary fatty acid composition for diets with different concentrations of fish oil  669 
Diet: Control LowFO ModFO 
FO g/kg diet:   0 3.1 12.5 
OO g/kg diet: 100 96.9 87.5 
Fatty acid  (g/kg) 
14:0 0 0.1 0.4 
16:0 10.4 10.7 11.6 
18:0 2.8 2.9 3.1 
18:1        (OA) 75.8 73.9 68.2 
18:2 n-6 (LA) 8.3 8.1 7.5 
18:3 n-3 (LNA) 0.5 0.5 0.5 
20:4 n-6 (AA) 0.1 0.2 0.3 
20:5 n-3 (EPA) 0 0.2 0.9 
22:5 n-3 (DPA) 0 0.1 0.1 
22:6 n-3 (DHA) 0 0.9 3.6 
Σ n-6 PUFA 8.7 8.5 8.0 
Σ n-3 PUFA 0.5 1.7 5.1 
n-6/n-3 PUFA ratio 16.63 5.05 1.56 
LA % en 1.92 1.87 1.72 
EPA % en 0 0.05 0.20 
DHA % en 0 0.20 0.83 
Total  fat % en 23.08 23.08 23.08 
 670 
Control diet (0% fish oil); LowFO: 0.31% fish oil diet; ModFO: 1.25% (moderate) fish oil diet.  671 
AA: arachidonic acid; DHA: docosahexaenoic acid; DPA: docosapentaenoic acid; EPA: 672 
eicosapentaenoic acid; LA: linoleic acid; LNA: linolenic acid; OA: oleic acid; OO: olive oil; 673 
PUFA: polyunsaturated fatty acid 674 
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Table 2. Percent fatty acid composition of membrane phospholipids of heart and hindlimb muscles from rats after dietary fish oil supplementation for 675 
15 weeks 676 
 Tissue: Gastrocnemius Soleus Left Ventricle 
 
Fatty acid: 












16:0                 §
 b
15.70 ± 0.83 a20.39 ± 0.97* a21.98 ± 2.18* c9.83 ± 0.56 b15.57 ± 0.63* a17.95 ± 0.68* c9.59 ± 0.18 c11.57 ± 0.21 b12.36 ± 0.10 
16:1               @
 a
0.63 ± 0.04 a0.71 ± 0.08 a0.88 ± 0.17 a0.75 ± 0.09 ab0.68 ± 0.09 a0.62 ± 0.05 b0.36 ± 0.02 b0.37 ± 0.04 b0.31 ± 0.02 
18:0                 §
 c
16.15 ± 0.76 c15.83 ± 0.58 c15.49 ± 0.66 b18.77 ± 0.45 b18.17 ± 0.65 a19.98 ± 0.82 a20.49 ± 0.13 a19.88 ± 0.24 a20.30 ± 0.36 
ΣSFA             §
 a
36.40 ± 1.06 a38.84 ± 1.27 40.30 ± 2.54 b32.94 ± 0.73 ab35.79 ± 0.51 40.23 ± 1.41* b30.11 ± 0.12 b33.46 ± 0.13 34.91 ± 0.30 
18:1                 ø
 b
10.32 ± 0.48 ab12.81 ± 0.57* b11.94 ± 0.32* a14.96 ± 1.08 a15.87 ± 0.68 b14.19 ± 0.64 a13.43 ± 0.21 b11.26 ± 0.20* b10.28 ± 0.29* 
ΣMUFA       ø
 b
12.14 ± 0.48 ab13.87 ± 0.61 13.19 ± 0.50 a17.72 ± 1.29 a16.99 ± 0.64 15.11 ± 0.62 b13.79 ± 0.20 b12.06 ± 0.20 11.01 ± 0.31 
18:2n-6            # 19.66 ± 0.85 16.80 ± 0.74 15.09 ±1.03* 20.68 ± 0.55 18.78 ± 0.54 17.59 ± 0.26* 21.17 ± 0.39 19.25 ± 0.71 18.08 ± 0.32* 
20:3n-6            ø
 a
0.78 ± 0.03 b0.51 ± 0.03* b0.51 ± 0.04* a0.80 ± 0.02  a0.63 ± 0.07* a0.67 ± 0.01 b0.55 ± 0.02 b0.51 ± 0.04 b0.53 ± 0.02 
20:4n-6           §
 b
15.85 ± 0.53 b11.47 ± 0.93* b7.01 ± 1.06*† b16.37 ± 0.41 b13.61 ± 0.81* b9.36 ± 0.61* a24.04 ± 0.37 a18.41 ± 0.45* a15.65 ± 0.55* 
22:4n-6           # 
b
0.39 ± 0.09 0.19 ±0.05 0.03 ± 0.03* a0.66 ± 0.06 0.31 ± 0.08* 0.06 ± 0.06*† a0.70 ± 0.04 0.32 ± 0.03* 0.12 ± 0.01*† 
22:5n-6           @ 
b
1.39 ± 0.11 0.35 ± 0.04* 0.40 ± 0.01* b1.24 ± 0.08 0.41 ± 0.05* 0.23 ± 0.08* a2.07 ± 0.10 0.62 ± 0.04* 0.57 ± 0.03* 
Σ n-6 PUFA   §
 b
41.23 ± 0.94 b28.99 ± 0.99* c22.97 ± 1.59*† b42.92 ± 1.10 b33.27 ± 1.23* b27.72 ± 0.81*† a48.54 ± 0.23 a38.83 ± 0.56* a34.88 ± 0.67*† 
20:5n-3  n.d. 0.16 ± 0.04* 0.36 ± 0.10*† n.d. 0.06 ± 0.04 0.29 ± 0.07* n.d. 0.05 ± 0.01 0.37 ± 0.04*† 
22:5n-3  
a
0.87 ± 0.05 0.86 ± 0.06 b0.85 ± 0.09 b0.71 ± 0.03 0.95 ± 0.06* a1.01 ± 0.08* b0.68 ± 0.04 0.79 ± 0.05 b0.91 ± 0.04* 
22:6n-3           #
 a
9.26 ±0.74 a19.89 ± 0.36* a24.25 ± 1.03*† b5.14 ± 0.23 b14.27 ± 0.65* b18.04 ± 1.40* b6.62 ± 0.34 b16.84 ± 0.38* b20.35 ± 0.68* 
Σ n-3 PUFA   §
 a
9.75 ± 0.63 a18.30 ± 0.30* a22.33 ± 1.02*† b5.62 ± 0.21 b13.35 ± 0.63* b16.93 ± 1.30* b7.30 ± 0.34 b15.65 ± 0.35* b19.21 ± 0.60* 
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ΣPUFA         @
 b
51.45 ± 0.89 b47.29 ± 0.76 b45.31 ± 2.16 b49.34 ± 1.07 b46.62 ± 1.36 b44.66 ± 1.81 a56.10 ± 0.15 a54.49 ± 0.27 a54.08 ± 0.47 
n-6/n-3 




4.33 ± 0.34 b1.59 ± 0.08* 1.03 ± 0.07* a7.71 ± 0.43 a2.51 ± 0.14* 1.68 ± 0.12* a6.72 ± 0.34 a2.49 ± 0.09* 1.83 ±0.09* 
PI                    ø
 
136 ± 3 a156 ± 2* a162 ± 7* 125 ± 1 b143 ± 4* b147 ± 7 * 134 ± 2 a166 ±2* a173 ± 2* 
 677 
Σ SFA = sum of saturated fatty acids; Σ MUFA = sum of monounsaturated fatty acids; Σ PUFA = sum of polyunsaturated fatty acids; PI = 678 
peroxidisability index (Peroxidisability index was calculated from the formula:  (% dienoic acids × 1) + (% trienoics × 2) + (% tetraenoics × 3) + (% 679 
pentaenoics × 4) + (% hexaenoics × 5).
(28)
 . Values are mean ± SEM. n= 4-6 per group. Within tissues (between diets): *p<0.05 vs. control diet (Table 680 
2); †p<0.05 vs. LowFO diet. Between tissues (within diets):  Values sharing a common letter superscript are not significantly different to other tissues 681 
within that diet.  Overall between tissues (all diet groups combined):  § p<0.05 LV ≠ sol ≠ gastroc; # p<0.05 gastroc ≠ sol, LV;  ø p<0.05 sol ≠ gastroc, 682 
LV; @ p<0.05 LV ≠ sol, gastroc. 683 
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Table 3. Effect of dietary FO on time (s) to decline to 50% of maximum for contraction and relaxation 684 
parameters of first and 25
th
 (last) contractions in repetitive 5s burst stimulation.  685 
 Contraction peak force Contraction rate Relaxation rate 
  +dT/dt max -dT/dt max 
DIET First Last First Last First Last 
Control    n=6 62 ±10s 35 ±  7s 48 ±  2s 33 ±5s 26 ±4s 18 ±2s 
Low FO   n=4 *110 ±15s *61 ±  8s *94 ±13s *51 ±8s *35 ±5s 21 ±3s 
ModFO   n=7 *117 ±14s *62 ±11s *96 ±12s *56 ±9s *37 ±3s *25 ±3s 
* P<0.05 vs control diet. 686 
  687 
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Figure Legends: 688 
Figure 1. Typical experimental trace from the contracting rat hindlimb illustrating force 689 
development during a 5 min stimulation protocol (5Hz, 5s duty cycle) with (inset) one 5s burst 690 
expanded to show the key derived measures of force and rate of force development (+/- 691 
dT/dtmax).  692 
 693 
Figure 2.  Effect of diet on force production (N.100g
-1
 muscle mass) of gastrocnemius/ soleus/ 694 
plantaris muscle bundle during repeated burst (5Hz, 5s duty-cycle) stimulation for 5 min.  (a) 695 
Force of the first contraction in each burst; (b) Force of the 25
th
 (last) contraction in each burst. 696 
Horizontal broken lines represent 50% of maximum contraction. (See Figure 1 for illustration)  697 
Arrows (solid = control diet; broken = FO diets) show coincidence of the (a) first and (b) 25
th
 698 
contraction in a burst with its decline to below 50% of maximum.  Bars represent mean ± SEM.  699 
Filled bars: Control diet n=6; Shaded bars: LowFO diet n=4; Open bars: ModFO diet n=7.   * 700 
LowFO, ModFO different to control, p< 0.05. 701 
 702 
Figure 3.  Effect of diet on differences in developed force (N.100g
-1
 muscle mass) within bursts 703 
(below axis) and recovery between bursts (above axis) of (5Hz, 5s duty-cycle) stimulation over 5 704 
min. Within burst changes represents short-term fatigue over 5s.  Between bursts represents 705 
recovery of contractile force in the first contraction of a new burst relative to the 25
th
 (last) 706 
contraction of the previous before. (See Figure 1 for illustration)   Bars represent mean ± SEM.  707 
Filled bars: Control diet n=6; Shaded bars: LowFO diet n=4: Open bars: ModFO diet n=7. † 708 
LowFO, ModFO different to control, p< 0.02; * LowFO, ModFO different to control, p< 0.05. 709 
 710 
Figure 4. Effect of diet on maximum rate of force development (dT.dt
-1
max above axis) and 711 
maximum rate of force decline (-dT.dt
-1





during repeated burst (5Hz, 5s duty-cycle) stimulation for 5 min. (a): first contraction; (b): 25
th
 713 
(last) contraction in each 5s burst. (See Figure 1 for illustration) Horizontal broken lines 714 
represent 50% of maximum.  Filled symbols: Control diet n=6; shaded symbols: LowFO diet 715 
n=4; open symbols: ModFO diet n=7. Symbols and bars represent mean ± SEM. † ModFO 716 
different to control, p< 0.02; * LowFO, ModFO different to control, p< 0.05. 717 
  718 
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